184 related articles for article (PubMed ID: 9538262)
1. Comparison of in vivo activities of 5'-connected and 3'-connected cis-acting ribozymes: selection of intracellularly active ribozymes using the gene for dihydrofolate reductase (DHFR) as a selective marker in Escherichia coli.
Hamada M; Fujita S; Kise H; Jigami Y; Taira K
J Biochem; 1998 Apr; 123(4):684-92. PubMed ID: 9538262
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of a single base change in a ribozyme using the gene for dihydrofolate reductase as a selective marker in Escherichia coli.
Fujita S; Koguma T; Ohkawa J; Mori K; Kohda T; Kise H; Nishikawa S; Iwakura M; Taira K
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):391-6. PubMed ID: 9012792
[TBL] [Abstract][Full Text] [Related]
3. A novel screening system for construction and selection of active ribozymes using DHFR (dihydrofolate reductase) gene as selection marker.
Koguma T; Ohkawa J; Mori K; Fujita S; Nishikawa S; Iwakura M; Taira K
Nucleic Acids Symp Ser; 1995; (34):221-2. PubMed ID: 8841631
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
[TBL] [Abstract][Full Text] [Related]
5. Dihydrofolate reductase gene as a versatile expression marker.
Iwakura M; Tanaka T
J Biochem; 1992 Jan; 111(1):31-6. PubMed ID: 1607361
[TBL] [Abstract][Full Text] [Related]
6. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
[TBL] [Abstract][Full Text] [Related]
7. Novel method for selection of tRNA-driven ribozymes with enhanced stability in mammalian cells.
Sano M; Kuwabara T; Warashina M; Fukamizu A; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):341-52. PubMed ID: 12477283
[TBL] [Abstract][Full Text] [Related]
8. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
[TBL] [Abstract][Full Text] [Related]
9. Modification and application of self-trimming hairpin ribozymes to targeting a transcribed RNA in vitro.
Komatsu Y; Shirai M; Ohtsuka E
J Biochem; 1998 Nov; 124(5):986-91. PubMed ID: 9792923
[TBL] [Abstract][Full Text] [Related]
10. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
11. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus.
Ohkawa J; Yuyama N; Takebe Y; Nishikawa S; Taira K
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11302-6. PubMed ID: 8248243
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
Bramlage B; Luzi E; Eckstein F
Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
[TBL] [Abstract][Full Text] [Related]
13. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.
Warashina M; Kuwabara T; Kato Y; Sano M; Taira K
Proc Natl Acad Sci U S A; 2001 May; 98(10):5572-7. PubMed ID: 11344300
[TBL] [Abstract][Full Text] [Related]
14. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
Ohkawa J; Yuyama N; Taira K
Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
Denman RB
Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
[TBL] [Abstract][Full Text] [Related]
16. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
Vaish NK; Heaton PA; Fedorova O; Eckstein F
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
[TBL] [Abstract][Full Text] [Related]
17. A hammerhead ribozyme inhibits the proliferation of an RNA coliphage SP in Escherichia coli.
Inokuchi Y; Yuyama N; Hirashima A; Nishikawa S; Ohkawa J; Taira K
J Biol Chem; 1994 Apr; 269(15):11361-6. PubMed ID: 8157667
[TBL] [Abstract][Full Text] [Related]
18. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
Ishizaka M; Ohshima Y; Tani T
Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
[TBL] [Abstract][Full Text] [Related]
19. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
Barrow EW; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
[TBL] [Abstract][Full Text] [Related]
20. RNA hairpin loops repress protein synthesis more strongly than hammerhead ribozymes.
Drew HR; Lewy D; Conaty J; Rand KN; Hendry P; Lockett T
Eur J Biochem; 1999 Nov; 266(1):260-73. PubMed ID: 10542074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
